13 days ago
TVTX
AnalystsVamil DivanVamil Divan's Stock Forecasts
AnalystsVamil Divan
Analyst Ranking
Top 4%
#170 out of 5315 analysts
Average Return
+20.2%
Win Rate
61%119 out of 195
Risk vs Reward
Poor
Good
Vamil Divan's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Cabaletta Bio IncCABA | +702.34% | $1.28 | $10.27 | 2022-05-25 - 2023-05-24 | Strong Buy |
Cabaletta Bio IncCABA | +313.27% | $1.96 | $8.10 | 2022-03-18 - 2023-03-17 | Strong Buy |
Insmed IncINSM | +265.91% | $20.36 | $74.50 | 2023-07-26 - 2024-07-25 | Strong Buy |
Insmed IncINSM | +185.36% | $26.37 | $75.25 | 2023-09-05 - 2024-09-04 | Strong Buy |
Revance Therapeutics IncRVNC | +170.20% | $13.22 | $35.72 | 2022-05-11 - 2023-05-11 | Strong Buy |
Vamil Divan Analyst Color
Get additional color on Vamil Divan's coverage of popular stocks
23 days ago
ABSI
2 months ago
JBIO
2 months ago
TVTX
3 months ago
TVTX
3 months ago
ABBV
3 months ago
ASMB
4 months ago
JBIO
8 months ago
JBIO
9 months ago
ABBV
10 months ago
INSM
10 months ago
ASMB
a year ago
ABBV
a year ago
JNJ
a year ago
PROK
a year ago
ABBV
a year ago
ANIP
a year ago
VERA
a year ago
MRK
a year ago
ABBV
2 years ago
JNJ
2 years ago
ABBV
2 years ago
VERA
2 years ago
TVTX
2 years ago
INSM
Vamil Divan's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Johnson & JohnsonJNJ | 13 | Strong Buy | $270.00 | +1.03% | Maintains | 12 days ago |
Travere Therapeutics IncTVTX | 10 | Strong Buy | $65.00 | +12.36% | Maintains | 13 days ago |
Absci CorpABSI | 4 | Strong Buy | $15.00 | +32.39% | Maintains | 23 days ago |
Assembly Biosciences IncASMB | 4 | Strong Buy | $43.00 | +48.46% | Reiterates | a month ago |
Unicycive Therapeutics IncUNCY | 3 | Strong Buy | $37.00 | +581.40% | Maintains | 2 months ago |
Draftkings IncDKNG | 1 | Strong Buy | $35.00 | +30.06% | Maintains | 2 months ago |
Jade Biosciences IncJBIO | 5 | Strong Buy | $32.00 | +42.54% | Maintains | 2 months ago |
Insmed IncINSM | 9 | Strong Buy | $226.00 | +100.28% | Maintains | 2 months ago |
Amgen IncAMGN | 4 | Hold | $340.00 | -7.63% | Maintains | 2 months ago |
Abbvie IncABBV | 25 | Strong Buy | $249.00 | -2.22% | Reiterates | 2 months ago |
Pfizer IncPFE | 16 | Strong Buy | $36.00 | +49.56% | Maintains | 3 months ago |
Merck & Co IncMRK | 8 | Strong Buy | $140.00 | +8.65% | Maintains | 5 months ago |
Ani Pharmaceuticals IncANIP | 14 | Strong Buy | $124.00 | +44.20% | Maintains | 6 months ago |
Eledon Pharmaceuticals IncELDN | 1 | Strong Buy | $8.00 | +103.56% | Maintains | 8 months ago |
Scynexis IncSCYX | 3 | Strong Buy | $24.00 | +420.61% | Maintains | 8 months ago |
Savara IncSVRA | 2 | Strong Buy | $11.00 | +77.13% | Maintains | 10 months ago |
Valneva SeVALN | 2 | Strong Buy | $13.00 | +147.15% | Maintains | 10 months ago |
Prokidney CorpPROK | 2 | Strong Buy | $7.00 | +258.97% | Maintains | a year ago |
Vera Therapeutics IncVERA | 5 | Strong Buy | $61.00 | N/A | Maintains | a year ago |
Revance Therapeutics IncRVNC | 6 | Hold | $3.10 | N/A | Maintains | 2 years ago |
Keros Therapeutics IncKROS | 2 | Strong Buy | $102.00 | N/A | Maintains | 2 years ago |
Alpine Immune Sciences IncALPN | 1 | Strong Buy | $55.00 | N/A | Initiates Coverage On | 2 years ago |
Karuna Therapeutics IncKRTX | 7 | Hold | $330.00 | N/A | Downgrades | 2 years ago |
Sage Therapeutics IncSAGE | 7 | Hold | $20.00 | N/A | Maintains | 3 years ago |
Calliditas Therapeutics AbCALT | 2 | Hold | $18.00 | N/A | Maintains | 3 years ago |
Relmada Therapeutics IncRLMD | 2 | Strong Buy | $26.00 | N/A | Reiterates | 3 years ago |
Chinook Therapeutics IncKDNY | 3 | Hold | $40.00 | N/A | Downgrades | 3 years ago |
Satsuma Pharmaceuticals IncSTSA | 5 | Hold | $2.00 | N/A | Downgrades | 4 years ago |
Acadia Pharmaceuticals IncACAD | 7 | Hold | $19.00 | N/A | Maintains | 4 years ago |
Neurocrine Biosciences IncNBIX | 5 | Hold | $98.00 | N/A | Maintains | 4 years ago |
Alkermes PLCALKS | 7 | Strong Buy | $34.00 | N/A | Maintains | 4 years ago |
Cabaletta Bio IncCABA | 3 | Strong Buy | $10.00 | N/A | Maintains | 4 years ago |
Axsome Therapeutics IncAXSM | 3 | Strong Buy | $49.00 | N/A | Maintains | 4 years ago |
Eli Lilly & CoLLY | 12 | Strong Buy | $356.00 | N/A | Maintains | 4 years ago |
Xeris Biopharma Holdings IncXERS | 1 | Strong Buy | $6.00 | N/A | Maintains | 4 years ago |
Biohaven Pharmaceutical Holding Co LtdBHVN1 | 9 | Strong Buy | $154.00 | N/A | Maintains | 4 years ago |
Evolus IncEOLS | 4 | Strong Buy | $15.00 | N/A | Upgrades | 5 years ago |
Allergan PLCAGN | 9 | Hold | $155.00 | N/A | Maintains | 7 years ago |
Teva Pharmaceutical Industries LtdTEVA | 10 | Hold | $20.00 | N/A | Maintains | 7 years ago |
Lakefront Biotherapeutics NvLKFT | 3 | Buy | N/A | N/A | Upgrades | 8 years ago |
Portola Pharmaceuticals IncPTLA | 6 | Hold | $30.00 | N/A | Maintains | 8 years ago |
Alder Biopharmaceuticals IncALDR | 2 | Hold | $17.00 | N/A | Maintains | 8 years ago |
Corvus Pharmaceuticals IncCRVS | 3 | Buy | $15.00 | N/A | Assumes | 8 years ago |
Aimmune Therapeutics IncAIMT | 3 | Buy | $40.00 | N/A | Maintains | 8 years ago |
Bristol Myers Squibb CoBMY | 2 | Hold | $61.00 | N/A | Maintains | 8 years ago |
Allena Pharmaceuticals IncALNAQ | 2 | Buy | $21.00 | N/A | Maintains | 8 years ago |
Esperion Therapeutics IncESPR | 2 | Buy | $103.00 | N/A | Initiates Coverage On | 8 years ago |
Myokardia IncMYOK | 1 | Buy | $55.00 | N/A | Maintains | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.